{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:29:58Z","timestamp":1776338998580,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pharma.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T11:05:26Z","timestamp":1654254326000},"page":"897-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Attitude of community pharmacists toward patients with a substance-related disorder (heroin, alcohol and tobacco), estimation of harmfulness and knowledge of these substances, and continuing education: A pilot cross-sectional study"],"prefix":"10.1016","volume":"80","author":[{"given":"D.","family":"Balayssac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Julien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Authier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vennat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2022.05.005_bib0235","series-title":"The global burden [Internet]. The global burden","author":"WHO - The World Health Organization","year":"2002"},{"key":"10.1016\/j.pharma.2022.05.005_bib0240","series-title":"Global status report on alcohol and health","first-page":"286","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.pharma.2022.05.005_bib0245","series-title":"WHO report on the Global Tobacco Epidemic, 2017: monitoring tobacco use and prevention policies (Who Reports) [Internet]","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.pharma.2022.05.005_bib0250","series-title":"World drug report 2017 [internet]","author":"United Nations Office on Drugs Crime","year":"2017"},{"key":"10.1016\/j.pharma.2022.05.005_bib0255","series-title":"Usages d\u2019alcool et dommages subis: une perspective europ\u00e9enne [Internet]","author":"Palle","year":"2017"},{"key":"10.1016\/j.pharma.2022.05.005_bib0260","first-page":"281","article-title":"La consommation de tabac en France et son \u00e9volution: r\u00e9sultats du barom\u00e8tre sant\u00e9 2014","volume":"17\u201318","author":"Guignard","year":"2015","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.pharma.2022.05.005_bib0265","series-title":"Donn\u00e9es r\u00e9centes relatives aux traitements de substitution aux opiac\u00e9s. Novembre 2013\u00a0\u2013\u00a0OFDT [Internet]","author":"Brisacier","year":"2013"},{"issue":"2","key":"10.1016\/j.pharma.2022.05.005_bib0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1503\/cmaj.111957","article-title":"Addiction is a disease: we must change our attitudes toward addicts","volume":"184","author":"Stanbrook","year":"2012","journal-title":"CMAJ Can Med Assoc J"},{"key":"10.1016\/j.pharma.2022.05.005_bib0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2017.04.009","article-title":"Broken lives: fights, fractures, and motor vehicle accidents among heroin users entering detoxification","volume":"177","author":"Stein","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharma.2022.05.005_bib0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ypmed.2015.04.015","article-title":"Alcohol misuse, firearm violence perpetration, and public policy in the United States","volume":"79","author":"Wintemute","year":"2015","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.pharma.2022.05.005_bib0285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1521-0391.2012.00332.x","article-title":"Physicians\u2019 beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists","volume":"22","author":"Lawrence","year":"2013","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.pharma.2022.05.005_bib0290","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13814788.2018.1470239","article-title":"Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice","volume":"24","author":"Dupouy","year":"2018","journal-title":"Eur J Gen Pract"},{"issue":"1","key":"10.1016\/j.pharma.2022.05.005_bib0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsat.2012.04.001","article-title":"Attitudes towards nicotine, alcohol and drug dependence among physicians in Israel","volume":"44","author":"Lev-Ran","year":"2013","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.pharma.2022.05.005_bib0300","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1186\/s12889-016-3805-3","article-title":"\u201cMaking the invisible visible\u201d through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study","volume":"16","author":"Hattingh","year":"2016","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.pharma.2022.05.005_bib0305","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2018.03.005","article-title":"A community pharmacy intervention for opioid medication misuse: a pilot randomized clinical trial","volume":"58","author":"Cochran","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.pharma.2022.05.005_bib0310","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.japh.2018.04.016","article-title":"Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline","volume":"58","author":"Hudmon","year":"2018","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.pharma.2022.05.005_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2014.11.006","article-title":"Factors associated with provision of addiction treatment information by community pharmacists","volume":"52","author":"Hagemeier","year":"2015","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"10.1016\/j.pharma.2022.05.005_bib0320","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.13593","article-title":"Effectiveness of pharmacy-based needle\/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis","volume":"112","author":"Sawangjit","year":"2017","journal-title":"Addict Abingdon Engl."},{"issue":"2S","key":"10.1016\/j.pharma.2022.05.005_bib0325","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.japh.2017.01.006","article-title":"Implementing take-home naloxone in an urban community pharmacy","volume":"57","author":"Akers","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.pharma.2022.05.005_bib0330","article-title":"Community pharmacies as access points for addiction treatment","author":"Look","year":"2018","journal-title":"Res Soc Adm Pharm RSA"},{"key":"10.1016\/j.pharma.2022.05.005_bib0335","article-title":"Promising roles for pharmacists in addressing the U.S. opioid crisis","author":"Compton","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.pharma.2022.05.005_bib0340","series-title":"Les pr\u00e9alables pour exercer l\u2019art pharmaceutique\u00a0\u2013\u00a0Le pharmacien\u00a0\u2013\u00a0Ordre national des pharmaciens [Internet]","author":"Ordre National des","year":"2017"},{"key":"10.1016\/j.pharma.2022.05.005_bib0345","series-title":"Docteur en pharmacie\u00a0\u2013\u00a0R\u00e9gime des \u00e9tudes en vue du dipl\u00f4me d\u2019\u00c9tat [Internet]","author":"Minist\u00e8re de de l\u2019Enseignement sup\u00e9rieur","year":"2013"},{"issue":"12","key":"10.1016\/j.pharma.2022.05.005_bib0350","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/pb.bp.109.028951","article-title":"Stigmatised attitudes in independent pharmacies associated with discrimination towards individuals with opioid dependence","volume":"34","author":"Luty","year":"2010","journal-title":"Psychiatrist"},{"key":"10.1016\/j.pharma.2022.05.005_bib0355","series-title":"Non-d\u00e9livrance des TSO: l\u2019observatoire des droits des usagers tire la sonnette d\u2019alarme [Internet]","author":"ASUD","year":"2018"},{"key":"10.1016\/j.pharma.2022.05.005_bib0360","series-title":"Pharmaciens et usagers, le dialogue n\u00e9cessaire [Internet]","author":"Debrus","year":"2007"},{"key":"10.1016\/j.pharma.2022.05.005_bib0365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2015.11.006","article-title":"Community pharmacy services for people with drug problems over two decades in Scotland: implications for future development","volume":"27","author":"Matheson","year":"2016","journal-title":"Int J Drug Policy."},{"issue":"11","key":"10.1016\/j.pharma.2022.05.005_bib0370","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1360-0443.2007.02016.x","article-title":"Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995\u20132005","volume":"102","author":"Sheridan","year":"2007","journal-title":"Addict Abingdon Engl."},{"issue":"6","key":"10.1016\/j.pharma.2022.05.005_bib0375","doi-asserted-by":"crossref","first-page":"693","DOI":"10.15288\/jsa.1993.54.693","article-title":"What's in a label? The effects of substance types and labels on treatment considerations and stigma","volume":"54","author":"Cunningham","year":"1993","journal-title":"J Stud Alcohol"},{"issue":"7","key":"10.1016\/j.pharma.2022.05.005_bib0380","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1192\/pb.30.7.257","article-title":"Validation of a short instrument to measure stigmatised attitudes towards mental illness","volume":"30","author":"Luty","year":"2006","journal-title":"Psychiatr Bull"},{"issue":"2","key":"10.1016\/j.pharma.2022.05.005_bib0385","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u00a0\u2013\u00a0a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.pharma.2022.05.005_bib0390","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"i5239","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.pharma.2022.05.005_bib0395","series-title":"Statistical power analysis for the behavioral sciences","first-page":"567","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pharma.2022.05.005_bib0400","series-title":"Drogues et addictions, donn\u00e9es essentielles\u00a0\u2013\u00a0alcool [internet]","author":"Palle","year":"2013"},{"key":"10.1016\/j.pharma.2022.05.005_bib0405","series-title":"Drug use: an overview of general population surveys in Europe [Internet]","author":"Decorte","year":"2009"},{"key":"10.1016\/j.pharma.2022.05.005_bib0410","series-title":"Drug-related knowledge, attitudes and beliefs in Ireland: report of a nation-wide survey","author":"Bryan","year":"2000"},{"key":"10.1016\/j.pharma.2022.05.005_bib0415","series-title":"State of the vitiviniculture world market [Internet]","author":"International Organisation of Vine Wine","year":"2018"},{"key":"10.1016\/j.pharma.2022.05.005_bib0420","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.foodres.2018.09.020","article-title":"French and Mediterranean-style diets: contradictions, misconceptions and scientific facts\u00a0\u2013\u00a0A review","volume":"116","author":"Ndlovu","year":"2019","journal-title":"Food Res Int Ott Ont"},{"key":"10.1016\/j.pharma.2022.05.005_bib0425","series-title":"The world drug perception problem: countering prejudices about people who use drugs [Internet]","author":"Global Commission on Drug Policy","year":"2017"},{"issue":"11","key":"10.1016\/j.pharma.2022.05.005_bib0430","doi-asserted-by":"crossref","first-page":"e021109","DOI":"10.1136\/bmjopen-2017-021109","article-title":"Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people","volume":"8","author":"Cheeta","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharma.2022.05.005_bib0435","series-title":"Perceptions et opinions des Fran\u00e7ais sur les drogues [Internet]","author":"Tovar","year":"2013"},{"issue":"5","key":"10.1016\/j.pharma.2022.05.005_bib0440","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5688\/ajpe80588","article-title":"A systematic review of the effects of continuing education programs on providing clinical community pharmacy services","volume":"80","author":"Obreli-Neto","year":"2016","journal-title":"Am J Pharm Educ"},{"key":"10.1016\/j.pharma.2022.05.005_bib0445","first-page":"CD003030","article-title":"Continuing education meetings and workshops: effects on professional practice and health care outcomes","volume":"2","author":"Forsetlund","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharma.2022.05.005_bib0450","series-title":"Vos droits\u00a0\u2013\u00a0refus de prescription ou de d\u00e9livrance [Internet]","author":"ASUD","year":"2013"},{"key":"10.1016\/j.pharma.2022.05.005_bib0455","series-title":"Article R4235-1, code de la sant\u00e9 publique [Internet]","author":"R\u00e9publique Fran\u00e7aise","year":"2004"},{"key":"10.1016\/j.pharma.2022.05.005_bib0460","series-title":"D\u00e9mographies des pharmaciens panorama au 1er janvier 2018 [Internet]","author":"Ordre national des pharmaciens","year":"2018"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:37:44Z","timestamp":1757720264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450922000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0003450922000591"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2022.05.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitude of community pharmacists toward patients with a substance-related disorder (heroin, alcohol and tobacco), estimation of harmfulness and knowledge of these substances, and continuing education: A pilot cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}